Zacks Investment Research on MSN

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note

Novavax (NVAX) ended the recent trading session at $8.46, demonstrating a -1.51% change from the preceding day's closing price. This change lagged the S&P 500's 0.53% loss on the day. Meanwhile, the ...

Novavax to Transfer a U.S. Facility, Sell Certain Assets to Net $60M in Cash

Assignment of the lease for the facility and sale of assets are expected to close in January and result in $40 million in payments to Novavax, while the sale of property adjacent to the headquarters ...

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential

Shah Capital urges Novavax to consider a sale after poor COVID-19 vaccine rollout, highlighting the potential value of at ...
Fierce Pharma

Consolidating Novavax transfers Maryland HQ lease to AstraZeneca in $60M deal

Novavax is slimming down again by striking a deal to transfer the lease to its Maryland corporate headquarters to AstraZeneca in exchange for nearly $60 million. | Novavax will remain headquartered at ...

Novavax to supply 40 mln doses of COVID-19 vaccine to Australia

Novavax Inc said on Wednesday it has signed an agreement with the Australian government to supply 40 million doses of its COVID-19 vaccine candidate, NVX-CoV2373.